Suchergebnisse - "Hanauer, Stephen B"

PubPharm (20)

1

Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease

enthalten in: Inflammatory bowel diseases | 2014

von Stein, A. | Rubin, D. | Hanauer, S. | +1

2

Comment on 'anti-adhesion therapies and the rule of 3 for rare events'

enthalten in: The American journal of gastroenterology | 2014

von Feagan, B. | Colombel, J. | Hanauer, S. | +4

CommentOn: Am J Gastroenterol. 2013 Dec;108(12):1831-2. - PMID 24300858

3

Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease

enthalten in: Inflammatory bowel diseases | 2013

von Sakuraba, A. | Annunziata, M. | Cohen, R. | +2

4

Natalizumab in Crohn's disease : results from a US tertiary inflammatory bowel disease center

enthalten in: Inflammatory bowel diseases | 2013

von Sakuraba, A. | Keyashian, K. | Correia, C. | +4

5

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

enthalten in: The New England journal of medicine | 2012

von Sandborn, W. | Gasink, C. | Gao, L. | +115

CommentIn: Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):690. - PMID 23147667

6

Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center

enthalten in: Inflammatory bowel diseases | 2012

von Cohen, R. | Lewis, J. | Turner, H. | +3

7

Efficacy of biological therapies in inflammatory bowel disease : systematic review and meta-analysis

enthalten in: The American journal of gastroenterology | 2011

von Ford, A. | Sandborn, W. | Khan, K. | +3

CommentIn: Am J Gastroenterol. 2011 Nov;106(11):2043; author reply 2044. - PMID 22056581

8

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization : when to start, when to stop, which drug to choose, and how to predict response?

enthalten in: The American journal of gastroenterology | 2011

von D'Haens, G. | Panaccione, R. | Higgins, P. | +25

ErratumIn: Am J Gastroenterol. 2011 Feb;106(2):375 Watermayer, G [corrected to Watermeyer, G]

9

Reinduction with certolizumab pegol in patients with relapsed Crohn's disease : results from the PRECiSE 4 Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2010

von Sandborn, W. | Schreiber, S. | Hanauer, S. | +4

10

Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2010

von Lichtenstein, G. | Thomsen, O. | Schreiber, S. | +105

CommentIn: Clin Gastroenterol Hepatol. 2010 Jul;8(7):556-8. - PMID 20417722